Clinical Trial Update: N-acetylcysteine Protects From Aminoglycosides Induced Nephrotoxicity [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 trials evaluated whether N-acetylcysteine can prevent aminoglycoside-related kidney injury; the studies have been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Soroka University Medical Center | Conditions: Drug Induced Nephrotoxicity | Phase 2, Phase 3 | Status: COMPLETED